Cargando…
Acute onset anterior uveitis after darbepoetin alfa infusion
A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notabl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621975/ https://www.ncbi.nlm.nih.gov/pubmed/26502332 http://dx.doi.org/10.1186/s12348-015-0061-0 |
_version_ | 1782397529029083136 |
---|---|
author | Li, Jonathan Orlin, Stephen E. Revere, Karen E. Kempen, John H. |
author_facet | Li, Jonathan Orlin, Stephen E. Revere, Karen E. Kempen, John H. |
author_sort | Li, Jonathan |
collection | PubMed |
description | A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notable for conjunctival injection and anterior chamber cell and flare consistent with anterior uveitis. She had no systemic symptoms, no history of eye trauma, and no known infections. This case, along with prior reports in the literature, suggests that anterior uveitis may be an idiosyncratic complication of darbepoetin alfa therapy. |
format | Online Article Text |
id | pubmed-4621975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-46219752015-10-30 Acute onset anterior uveitis after darbepoetin alfa infusion Li, Jonathan Orlin, Stephen E. Revere, Karen E. Kempen, John H. J Ophthalmic Inflamm Infect Letter to the Editor A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notable for conjunctival injection and anterior chamber cell and flare consistent with anterior uveitis. She had no systemic symptoms, no history of eye trauma, and no known infections. This case, along with prior reports in the literature, suggests that anterior uveitis may be an idiosyncratic complication of darbepoetin alfa therapy. Springer Berlin Heidelberg 2015-10-26 /pmc/articles/PMC4621975/ /pubmed/26502332 http://dx.doi.org/10.1186/s12348-015-0061-0 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Letter to the Editor Li, Jonathan Orlin, Stephen E. Revere, Karen E. Kempen, John H. Acute onset anterior uveitis after darbepoetin alfa infusion |
title | Acute onset anterior uveitis after darbepoetin alfa infusion |
title_full | Acute onset anterior uveitis after darbepoetin alfa infusion |
title_fullStr | Acute onset anterior uveitis after darbepoetin alfa infusion |
title_full_unstemmed | Acute onset anterior uveitis after darbepoetin alfa infusion |
title_short | Acute onset anterior uveitis after darbepoetin alfa infusion |
title_sort | acute onset anterior uveitis after darbepoetin alfa infusion |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621975/ https://www.ncbi.nlm.nih.gov/pubmed/26502332 http://dx.doi.org/10.1186/s12348-015-0061-0 |
work_keys_str_mv | AT lijonathan acuteonsetanterioruveitisafterdarbepoetinalfainfusion AT orlinstephene acuteonsetanterioruveitisafterdarbepoetinalfainfusion AT reverekarene acuteonsetanterioruveitisafterdarbepoetinalfainfusion AT kempenjohnh acuteonsetanterioruveitisafterdarbepoetinalfainfusion |